Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 52.29B | 52.95B | 49.48B | 44.82B | 38.81B | 35.67B |
Gross Profit | 12.33B | 12.21B | 11.40B | 9.61B | 8.66B | 6.44B |
EBITDA | 5.39B | 5.70B | 4.96B | 4.27B | 5.57B | 859.00M |
Net Income | 2.82B | 2.47B | 2.25B | 1.77B | 2.14B | -2.17B |
Balance Sheet | ||||||
Total Assets | 63.11B | 67.07B | 63.07B | 60.63B | 58.94B | 57.14B |
Cash, Cash Equivalents and Short-Term Investments | 5.64B | 5.93B | 5.97B | 9.99B | 11.11B | 5.98B |
Total Debt | 2.04B | 3.56B | 2.33B | 3.01B | 4.20B | 5.15B |
Total Liabilities | 15.18B | 17.61B | 15.68B | 15.72B | 15.95B | 16.07B |
Stockholders Equity | 47.94B | 49.46B | 47.39B | 44.91B | 42.98B | 41.05B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 324.00M | -2.83B | -174.00M | 2.28B | -5.70B |
Operating Cash Flow | 0.00 | 4.70B | 3.66B | 3.50B | 3.95B | -815.00M |
Investing Cash Flow | 0.00 | -5.29B | -6.47B | -3.31B | 2.63B | -4.02B |
Financing Cash Flow | 0.00 | 554.00M | -1.23B | -1.36B | -1.43B | 3.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.85B | 8.17 | 3.72% | 4.70% | 8.98% | ||
80 Outperform | ¥22.45B | 8.00 | 0.75% | 3.89% | -45.94% | ||
76 Outperform | ¥13.43B | 9.73 | 3.71% | 4.04% | -13.19% | ||
76 Outperform | ¥21.50B | 12.04 | 2.55% | 18.43% | 19.44% | ||
75 Outperform | ¥19.94B | 12.99 | 1.09% | 12.23% | 32.58% | ||
75 Outperform | ¥21.47B | 8.70 | 1.68% | 7.02% | 9.68% | ||
61 Neutral | C$6.60B | 7.22 | 3.42% | 2.83% | 6.74% | -16.67% |